Clinical Guest Contributors

1. U.S. Tariffs And Their Tenuous Impact On Clinical Trials 6/10/2025

   RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.

2. 6 Tips To Ensure Revenue Integrity And Compliance In Clinical Operations 6/9/2025

   Discover the importance of Medicare Coverage Analysis (MCA) and the rules of National Coverage Determination (NCD) in establishing financial security and regulatory adherence in clinical operations.

3. When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover 6/6/2025

   Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. shares a near-catastrophic CRO experience and explains how his team rebounded just in time.

4. Evolving Neurology And Neuroinflammation Therapies And Trials In 2025 6/5/2025

   Could 2025 be the year that advancements in brain health and increased funding for innovative therapies make a difference for neuroinflammation therapies and trials? Immunic CEO Daniel Vitt, Ph.D., discusses.

5. Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EU 6/4/2025

   Discover how to secure uninterrupted access to long-term trial data for CAR-T therapies by participating in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T Data Collection Initiative. 

6. Regeneron Trials Balance Quest For "Scientific Truth" With Patient Impact 6/3/2025

   Regeneron’s Andres Sirulnik, MD, Ph.D., discusses the importance of seeking "scientific truth" and an unwavering commitment to patient centricity in the context of the company’s hematology research.

7. Radiopharmaceuticals: Navigating FDA Guidance And CMC Considerations 6/2/2025

   The unique nature of radiopharmaceuticals necessitates specialized regulatory considerations, particularly for chemistry, manufacturing, and controls (CMC).

8. The Future Of Clinical Trials Is Neurodiverse 6/2/2025

   If we want efficient and equitable trials, says Brianna Polite, we must include clinical research professionals across the spectrum of human cognition, particularly neurodivergent thinkers.

9. In The Age Of AI, Data Is Still King 5/29/2025

   While AI captures attention, data quietly runs the show, says Empactful Ventures Founder Denise Bronner, Ph.D. She explains why proprietary data sets are the foundation of everything AI promises to deliver.

10. Never Underestimate The Power Of Clinical Operations 5/28/2025

    Too often, clinical operations is treated as a transactional or downstream function, says clinical operations strategist Suzanne Vyvoda. She wants to change how we see and treat ClinOps.